Picture of Kingworld Medicines logo

1110 Kingworld Medicines Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Annual cashflow statement for Kingworld Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line69.467.693.995.557.4
Depreciation
Amortisation
Non-Cash Items7.049.64-9.89-10.1-2.58
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-30.171.1-61.830.23.71
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities81.218742.313684.6
Capital Expenditures-58.3-93.5-106-41.1-29.6
Purchase of Fixed Assets
Other Investing Cash Flow Items7.489.46-15.113.59.54
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-50.8-84-121-27.6-20.1
Financing Cash Flow Items-13.2-58.2-33.3-60.8-36.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-87.2-51.34.37-47.6-30.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-62.954.2-68.561.629.1